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Background: The purpose of this study was to explore the prevalence and associated factors of gallstone
disease among elderly patients with type 2 diabetes ( 60 years) in Kinmen, Taiwan.
Methods: In 2001, a panel of specialists performed ultrasound sonography screening on 594 elderly type
2 diabetic patients identiﬁed in 1991e1993. Of these, 298 (50.2%) patients were examined.
Results: Fifty-one out of 298 elderly type 2 diabetic patients were diagnosed with gallstone disease. The
overall prevalence was 17.1% (men: 14.5%, women: 19.0%), which included the presence of single stone,
9.1% (n ¼ 27); multiple stones, 4.4% (n ¼ 13); and cholecystectomy, 3.7% (n ¼ 11). The signiﬁcant risk
factors of gallstone disease based on multiple logistic regression analysis were body mass index [odds
ratio (OR) ¼1.21, 95% conﬁdence interval (CI): 1.09e1.37] and alanine transaminase (OR ¼ 1.06, 95% CI:
1.03e1.10).
Conclusion: The elderly type 2 diabetic population had a slightly higher prevalence of gallstone disease
than the general population but no statistical signiﬁcance. A higher body mass index and alanine
transaminase may increase the risk of developing gallstone disease.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Gallstone diseases (GSD), including asymptomatic, symptom-
atic, and complicated syndrome, are frequently seen in the elderly,
and the prevalence of the disease increases proportionally with age.
At higher ages (>60 years) the presentation of symptomatic or
complicated GSD is frequently atypical1. Previous evidence-based
studies exploring GSD in the elderly have focused almost entirely
on outcomes of interventions, such as percutaneous chol-
ecystostomy, endoscopic retrograde cholangiopancreatography
(ERCP), or the management of elderly patients from the moment of
presentation at the hospital with symptomatic biliary disease2e6.
Investigating the epidemiologic characteristics of GSD amongerest.
n General Hospital, Shih-Pai,
iwan Society of Geriatric Emergenelderly type 2 diabetic patients is necessary to help identify the best
treatment strategies.
The morbidity of GSD has recently increased in the Chinese
population due to an increasedwesternization of dietary habits and
a decrease in physical activity7e9. Some controversy exists as to
whether type 2 diabetes is related to GSD. Some epidemiologic
studies have concluded that diabetes was a risk factor for GSD9, but
such an association has not been observed consistently in other
population-based studies7,10. Type 2 diabetic patients with GSD
may be more likely to induce acute cholecystitis, have a higher
likelihood to progress to septicemia, and secrete more lithogenic
bile than nondiabetic patients7. Previous studies also demonstrated
that the prevalence of GSD among the type 2 diabetic population
was higher than in the normal population7,9.
Because GSD can result in serious outcomes, such as acute
gallstone pancreatitis and gallbladder cancer11, studying which
factors contribute to the development of GSD is important8. From
a public health viewpoint, identifying the demographic and bio-
logic markers related to the development of GSD is essential. Our
previous community-based study revealed the prevalence of
overall GSD among type 2 diabetic patients7. To identify thecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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2 diabetic patients, we assessed an elderly subgroup in Kinmen,
Taiwan.
2. Materials and methods
2.1. Data resources
The details of the study design and execution have been
described in full elsewhere7. The diagnosis of type 2 diabetes was
based on the 1999 WHO deﬁnition12. A population survey per-
formed in Kinmen, Taiwan, from 1991 to 1993 identiﬁed 1123 type
2 diabetic patients 30 years of age and older. After excluding those
who migrated or died, 858 participants remained to form a cohort
that received abdominal ultrasonography. In 2001, they were
invited by telephone or mail to receive screening for GSD. Of the
594 (269 were aged 60e69 years and 325 were aged  70 years)
patients that responded, 298 (50.2%) included 157 aged 60e69
years (58.4%) and 141 aged  70 years (43.4%) agreed to the
screening. Informed consent was obtained from all participants
before the survey was conducted.
2.2. Data collection
Baseline information was collected from 1991 to 1993. Face-to-
face interviews were conducted by the Yang-Ming Crusade, a well-
trained group of medical students from National Yang-Ming
University, Taipei, Taiwan. Public health nurses took fasting blood
samples. Overnight fasting serum and plasma samples (preserved
with ethylenediaminetetraacetates (EDTA) and Sodium ﬂouride
(NaF)) were collected and kept frozen (e20C) until analysis. Fast-
ing plasma glucose (FPG) concentrations were determined using
the hexokmase-glucose-6-phosphate dehydrogenase method with
a glucose (HK) reagent ldt (Gilford, Oberlin, OH, USA).
The follow-up screening regime for GSD was performed in 2001.
A panel of specialists diagnosed GSD based on the presence of
“movable hyperechoic material with acoustic shadow7,13.” Real-
time ultrasonography examined the abdominal region after the
participants had fasted for at least 8 hours. Cases of GSD were
classiﬁed as follows: single gallbladder stone, multiple gallbladder
stones, and cholecystectomy, excluding gallbladder polyps. The
noncases were identiﬁed as no GSD among type 2 diabetic patients.
2.3. Interobserver reliability in ultrasonography
The Kappa statistic was used to assess interobserver reliability
and to establish a consistent diagnosis of GSD between twoTable 1
Prevalence of gallstone disease among elderly patients with type 2 diabetes in Kinmen,
Variable
Total Subtotal Si
Diabetics Prevalence P
No. No. (%) No.
Sex
Men 124 18 14.5 9
Women 174 33 19.0 18
Age (yr)
60e69 157 23 14.7 9
70e79 109 22 20.2 13
80þ 32 6 18.8 5
Total 298 51 17.1 27
a Cochran-Armitage trend test for age (z ¼ 2.09, p ¼ 0.037).specialists. The pilot study was performed with 50, randomly
selected, type 2 diabetic patients who did not participate in the
ﬁnal study. The Kappa value for diagnosis of GSD was 0.77 [95%
conﬁdence interval (CI): 0.50e0.96] for interobserver reliability.
2.4. Statistics analysis
Statistical analysis was performed using SAS 9.1 software (SAS
Institute Inc., Cary, NC, USA). In the univariate analysis, an inde-
pendent t-test was applied for continuous variables. Multiple
logistic regression was used to investigate the independence of
factors related to GSD. An odds ratio (OR) and 95% CI were used for
categorical variables. A p value of < 0.05 was considered statisti-
cally signiﬁcant.
3. Results
The majority of baseline factors related to the risk of GSD in
elderly type 2 diabetic patients were similar to those in non-
attendants except that the age of nonattendants was signiﬁcantly
older (75.3  7.9 vs. 70.7  7.21 years) and FPGs were higher
(158.7  49.2 vs. 143.4  54.8 mg/dl) than attendants. Other
baseline biochemical factors [including systolic blood pressure
(SBP), diastolic blood pressure (DBP), total cholesterol, triglyceride,
high- and low-density lipoprotein, blood urea nitrogen, creatinine,
uric acid, body mass index (BMI), and waistehip ratio] associated
with the risk of type 2 diabetes for attendants were not signiﬁcantly
different from those for nonattendants. The male (124/240, 51.6%)
participants had a slightly higher response rate than the females
(174/354, 49.2%), and adults aged 60e69 years (58.4%) had a higher
response rate than other age groups.
Table 1 shows that the overall prevalence of GSD among elderly
type 2 diabetic patients was 17.1% [9.1% (n ¼ 27) for a single stone,
4.4% (n ¼ 13) for multiple stones, and 3.7% (n ¼ 11) for cholecys-
tectomy]. The occurrence in elderly women (19.0%) was not
statistically higher than that in men (14.5%) (c2 ¼ 1.01, p ¼ 0.32).
The Cochran-Armitage trend test found that single GSD displayed
an increase with age (z ¼ 2.09, p ¼ 0.037) but did not ﬁnd in
multiple stones and cholecystectomy.
As Table 2 shows, baseline factors that were signiﬁcantly related
to GSD included age [cases (74.6 7.6 years) vs noncases (70.5 7.0
years); t¼ 2.88, p¼ 0.03] BMI [cases (26.7 3.8 kg/m2) vs noncases
(25.1  3.6 kg/m2); t ¼ 3.17, p ¼0.004], SBP [cases
(148.5  22.7 mmHg) vs noncases (142.5  22.7 mmHg); t ¼ 2.66,
p¼ 0.03], and alanine transaminase (ALT) [cases (31.5 36.6 U/L) vs
noncases (24.6  20.3 U/L); t ¼ 2.04, p ¼ 0.04] from a two-sample
independent t-test.Taiwan, 2001 (n ¼ 298).
Gallstone disease
ngle stone Multiple stones Cholecystectomy
revalencea Prevalence Prevalence
(%) No. (%) No. (%)
7.3 5 4.0 4 3.2
10.3 8 4.6 7 4.0
5.7 7 4.5 7 4.5
11.9 6 5.5 3 2.8
15.6 0 0.0 1 9.1
9.1 13 4.4 11 3.7
Table 2
Comparison of characteristics between controls and those with gallstone disease among elderly people with type 2 diabetes in Kinmen, Taiwan (n ¼ 298).
Variables Elderly patients with type 2 diabetes
GSD (n ¼ 51)
Mean  SD
Non-GSD (n ¼ 247)
Mean  SD
Total (n ¼ 298)
Mean  SD
p-value for t-test
Age (yr) 74.6  7.6 70.5  7.0 72.7  7.2 0.02
Duration of diabetes (yr) 9.5  2.1 9.2  2.0 9.3  2.1 0.65
FPG (mg/dl) 143.9  43.8 143.3  56.9 143.4  54.8 0.94
BMI (kg/m2) 26.7  3.8 25.1  3.6 25.4  3.7 0.004
SBP (mmHg) 148.5  22.7 142.5  22.7 143.5  22.8 0.03
DBP (mmHg) 86.5  13.5 84.6  12.8 85.0  13.0 0.36
Triglycerides (mg/dl) 118.9  60.9 135.8  79.4 133.0  76.9 0.24
Total cholesterol (mg/dl) 213.1  43.7 218.6  43.5 217.8  43.5 0.49
HDL (mg/dl) 55.3  33.1 54.5  30.2 54.6  30.6 0.89
AST (U/L) 25.2  17.1 23.0  12.8 23.3  13.6 0.37
ALT (U/L) 31.5  36.6 24.6  20.3 25.7  23.6 0.04
Uric acid (mg/dl) 5.7  1.3 6.0  1.7 6.0  1.6 0.31
ALT ¼ alanine transaminase; AST ¼ aspartate aminotransferase; BMI ¼ body mass index; DBP ¼ diastolic blood pressure; FPG ¼ fasting plasma glucose; HDL ¼ high-density
lipoprotein; SBP ¼ systolic blood pressure; SD ¼ standard deviation.
W.-Y. Hou et al.40The effects of independent risk factors for GSD after adjustment
for confounding factors; that is, all univariate signiﬁcant factors
were examined with the multiple logistic regression model using
enter method. Table 3 shows that the independent risk factors for
GSD were BMI (OR ¼ 1.21, 95% CI: 1.09e1.37) and ALT (OR ¼ 1.06,
95% CI: 1.03e1.10).4. Discussion
4.1. Clinical implications
GSD with complications (especially cholecystitis and chol-
angitis) in the elderly is associated with high morbidity and high
mortality rates1. The introduction of laparoscopic cholecystectomy
has decreased the morbidity and mortality rates of symptomatic
and complicated GSD in the elderly14. Cholecystectomy is also
recommended for patients who suffer from biliary colic acute
cholecystitis, cholangitis, or pancreatitis. The actual symptoms
caused fromGSD are not completely understood, making it difﬁcult
to deﬁne those that will be cured by cholecystectomy15. Cholecys-
tectomy is safe and should be offered to patients when speciﬁc GSD
symptoms appear, unless the patient’s age is too advanced or
a coexisting medical illness is present16. Older patients with severe
disease often undergo more conservative treatment strategies6.
ERCP with sphincterotomy is the selective treatment for common
bile duct stones in the elderly. Whether or not the presence of bile
duct stones is accompanied by cholangitis or pancreatitis, a lapa-
roscopic cholecystectomy should be performed after removal of the
common bile duct stones, unless contraindications are present1.
In this study, the prevalence GSD of type 2 diabetes was higher
in the elderly than in younger diabetic patients or the general
population using the same methodology of GSD assessment as in
previous reports7,9. A study of senior citizens in Taiwan also
demonstrated that being older than 60 years of age was the mostTable 3
Multiple logistic regression on the risk factors associated with gallstone disease
among elderly patients with type 2 diabetes in Kinmen, Taiwan (n ¼ 298).
Variables GSD vs non-GSD
OR 95% CI p value
BMI (kg/m2) 1.21 1.09e1.37 0.003
ALT (U/L) 1.06 1.03e1.10 0.04
Independent variables included all univariate signiﬁcant factors: sex, age, BMI, SBP,
and ALT.
ALT ¼ alanine transaminase; BMI ¼ body mass index; CI ¼ conﬁdence interval; GSD
gallstone diseases; SBP ¼ systolic blood pressure.important risk factor for the development of GSD17. A long-term
exposure to associated risk factors among the elderly, such as
a longer duration of type 2 diabetes, may account for their
increased chance of developing GSD13,17. Chronic environmental
factors added to the effect of aging can also cause cholelithiasis3.
However, we not only found through multiple logistic regression
that age was not related to GSD, but also showed that age was not
related to multiple GSD and cholecystectomy by Cochran-Armitage
trend test for age groups. In addition to underestimate of disease
prevalence due to lower response rate of older patients, this also
implies that the pathogenesis of GSD is multifactorial and probably
develops from complex interactions between many genetic and
environmental factors that have increasing inﬂuence with aging8.
A higher BMI showed a positive association with GSD in elderly
type 2 diabetic patients. Obesity can raise the saturation of bile by
increasing the biliary secretion of cholesterol18. Being overweight
at baseline was strongly associated with the incidence of GSD,
which has also been suggested in epidemiologic studies19. Further
epidemiologic and etiologic investigations are needed to explore
the pathophysiological mechanism that exists between obesity and
GSD among elderly diabetic patients.
ALT is a sensitive indicator of liver-cell injury20. The determi-
nation of serum ALT levels constitutes the most frequently applied
test for the identiﬁcation of patients suffering from liver disease18.
This parameter also acts as a surrogate marker for disease severity
and/or as an index of hepatic activity21. We have also conﬁrmed
that elevated ALT levels constitute a higher risk for GSD develop-
ment. This implies that appropriate integrated diagnosis and
therapy in the early stage of liver dysfunction might eventually
enable us to prevent GSD in elderly diabetic patients. In addition,
previous study showed that obesity was signiﬁcantly related to an
elevated serum ALT level22. The slighter correlation (r ¼ 0.26,
p ¼ 0.03) was also found between BMI and ALT in this study.
However, due to the cross-sectional study design was used, we
could not clarify the temporal effect between BMI, ALT, and GSD.
Further studies should be conducted to determine if elevated ALT
levels can serve as an indicator for GSD. Such elevated levels indi-
cate a fatty liver (and thus a high BMI) and the early stage of chronic
liver disease. It may, however, be a sign of more serious liver
diseases like cirrhosis.4.2. Perceived limitations
One of the major limitations of the study was a potential
selection bias due to the lower response rate of older patients.
Nevertheless, given the rather large sample size of this study, we
Gallstone Disease among Elderly Diabetic Patients 41were still able to evaluate the signiﬁcance of associated risk factors
for GSD. Another limitation was that using different methodologies
for GSD assessment could have affected the prevalence compari-
sons. In addition, the screening program for GSD in type 2 diabetic
patients was conducted 8 years after the mass screening. Some bias
due to the delayed diagnosis of GSD could have occurred. Finally,
our measurements were conducted at only a single point in time
and cannot be used to reﬂect long-term exposure to various
demographic or biochemical factors, which might inﬂuence the
development of GSD. The solution to such a quandary would best
be accomplished by conducting a number of prospective longitu-
dinal analogous studies, the results of which would be expected to
complement the community-based (cross-sectional) ﬁndings of
this study.
5. Conclusion
Our results found that the elderly type 2 diabetic population has
a slightly higher prevalence of GSD than the general population but
no statistical signiﬁcance. A higher BMI and a higher ALT may
increase the risk of developing gallstone disease in elderly type 2
diabetic patients.
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